Back
Day Range
$215.80
$222.98
52-Week Range
$124.06
$248.60
Volume
291,636
50D / 200D Avg
$225.73
/
$202.09
Prev Close
$215.54
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -61.9 | 0.2 |
| P/B | — | 3.0 |
| ROE % | — | 3.6 |
| Net Margin % | -31.7 | 3.8 |
| Rev Growth 5Y % | 207.1 | 10.0 |
| D/E | — | 0.2 |
Analyst Price Target
Hold
$287.17
+30.0%
Low: $250.00
High: $342.00
Forward P/E
52.32
Forward EPS
$4.22
EPS Growth (est.)
+0.0%
Est. Revenue
1.39B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$23.00
$19.34 – $26.46
|
3.41B | 5 |
| FY2029 |
$20.07
$16.87 – $23.08
|
3.06B | 2 |
| FY2028 |
$15.87
$10.83 – $21.46
|
2.53B | 7 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-11 | -$0.11 | -$0.64 | -471.0% |
| 2025-11-12 | -$0.41 | -$1.17 | -185.4% |
| 2025-08-07 | -$1.42 | -$0.93 | +34.5% |
| 2025-05-01 | -$1.56 | -$1.66 | -6.4% |
| 2025-02-12 | -$1.20 | -$0.68 | +43.3% |
| 2024-11-14 | -$1.83 | -$1.81 | +1.1% |
| 2024-09-03 | -$1.54 | -$2.05 | -33.1% |
| 2024-05-02 | -$1.62 | -$2.48 | -53.3% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue grew 207.09% annually over 5 years — strong growth
Generating 43.62M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 116.87%
Capital efficient — spends only 1.18% of revenue on capex
Growth
Revenue Growth (5Y)
207.09%
Revenue (1Y)90.22%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC-13.85%
Net Margin-31.67%
Op. Margin-18.92%
Safety
Debt / Equity
N/A
Current Ratio1.04
Interest Coverage-1.69
Valuation
P/E Ratio
-61.90
Forward P/E52.32
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 90.22% | Revenue Growth (3Y) | 61.04% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 207.09% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 691.71M | Net Income (TTM) | -219.03M |
| ROE | N/A | ROA | -16.82% |
| Gross Margin | 85.08% | Operating Margin | -18.92% |
| Net Margin | -31.67% | Free Cash Flow (TTM) | 43.62M |
| ROIC | -13.85% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1.04 |
| Interest Coverage | -1.69 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -61.90 | Forward P/E | 52.32 |
| P/B Ratio | N/A | P/S Ratio | 19.60 |
| PEG Ratio | 1.13 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 9.77 | Fwd Earnings Yield | 1.91% |
| FCF Yield | 0.32% | ||
| Market Cap | 13.56B | Enterprise Value | 13.81B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 691.71M | 363.64M | 266.72M | 51.17M | 7.78M |
| Net Income | -219.03M | -378.08M | -481.45M | -583.19M | -383.58M |
| EPS (Diluted) | -3.62 | -6.53 | -8.55 | -10.40 | -7.00 |
| Gross Profit | 588.53M | 319.38M | 222.32M | 39.04M | 4.26M |
| Operating Income | -130.89M | -278.76M | -455.54M | -561.81M | -451.79M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.30B | 1.18B | 825.59M | 1.09B | 1.08B |
| Total Liabilities | 1.46B | 1.29B | 971.28M | 826.39M | 201.29M |
| Shareholders' Equity | -162.75M | -105.71M | -145.70M | 263.35M | 883.64M |
| Total Debt | 871.41M | 856.62M | 743.06M | 617.57M | 209.92M |
| Cash & Equivalents | 615.78M | 559.54M | 392.16M | 444.77M | 446.27M |
| Current Assets | 1.11B | 1.06B | 702.72M | 923.47M | 805.89M |
| Current Liabilities | 1.07B | 907.86M | 736.51M | 716.78M | 100.36M |